Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sei Keng Koh

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Therapeutics and Clinical Risk Management|October 2, 2008
The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushesAlex C Spyropoulos, Sharyl Magnuson, Sei Keng Koh
Journal of Thrombosis and Thrombolysis|April 17, 2010
Validity of current recommendation for peri-operative interruption of warfarin in AsiansSei Keng Koh, Heng Joo Ng, Ming Chai Kong, et al.
Mededpublish (2016)|February 26, 2024
The use of portfolio to support competency-based professional development of pharmacists in a Singapore tertiary hospitalSei Keng Koh, Camilla Ming Lee Wong, Mei Ling Yee, et al.
Currents in Pharmacy Teaching & Learning|November 17, 2023
Development of a pharmacy educational environment questionnaireTing Ting Yeoh, Koon Mian Foo, Sei Keng Koh, et al.
Hematology (Amsterdam, Netherlands)|March 7, 2022
A correlation of thrombin generation assay and clot waveform analysis in patients on warfarinMay Anne Cheong, Chuen Wen Tan, Wan Hui Wong, et al.
Journal of Clinical Pathology|January 25, 2019
Generational performance of three point-of-care testing devices compared with standard laboratory measurement of the international normalised ratio across extended rangesHui Ming Tay, Yi Feng Lai, Ming Chai Kong, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Therapeutics and Clinical Risk Management|October 2, 2008
The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushesAlex C Spyropoulos, Sharyl Magnuson, Sei Keng Koh
Journal of Thrombosis and Thrombolysis|April 17, 2010
Validity of current recommendation for peri-operative interruption of warfarin in AsiansSei Keng Koh, Heng Joo Ng, Ming Chai Kong, et al.
Mededpublish (2016)|February 26, 2024
The use of portfolio to support competency-based professional development of pharmacists in a Singapore tertiary hospitalSei Keng Koh, Camilla Ming Lee Wong, Mei Ling Yee, et al.
Currents in Pharmacy Teaching & Learning|November 17, 2023
Development of a pharmacy educational environment questionnaireTing Ting Yeoh, Koon Mian Foo, Sei Keng Koh, et al.
Hematology (Amsterdam, Netherlands)|March 7, 2022
A correlation of thrombin generation assay and clot waveform analysis in patients on warfarinMay Anne Cheong, Chuen Wen Tan, Wan Hui Wong, et al.
Journal of Clinical Pathology|January 25, 2019
Generational performance of three point-of-care testing devices compared with standard laboratory measurement of the international normalised ratio across extended rangesHui Ming Tay, Yi Feng Lai, Ming Chai Kong, et al.
Pageof 1